Leerink Partnrs Forecasts Increased Earnings for Genmab A/S
Genmab A/S (NASDAQ:GMAB – Free Report) – Stock analysts at Leerink Partnrs lifted their FY2025 earnings per share estimates for shares of Genmab A/S in a research note issued on Thursday, May 8th. Leerink Partnrs analyst J. Chang now forecasts that the company will earn $1.68 per share for the year, up from their prior […]
